Artivion, Inc. (AORT) vs PROCEPT BioRobotics Corporation (PRCT)

Artivion, Inc. and PROCEPT BioRobotics Corporation are both Medical Devices companies. Artivion, Inc. and PROCEPT BioRobotics Corporation are of similar size ($1.1B and $1.0B). PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against 16.4%. Artivion, Inc. has the higher net margin (−0.67% vs −32.5%) and the higher return on invested capital (1.76% vs −43.6%). Across the 18 metrics below, Artivion, Inc. leads on 12 and PROCEPT BioRobotics Corporation on 6.

Valuation

Metric AORT PRCT Medical Devices median
P/E n/m n/m 23.22
P/S 2.24 2.97 2.34
P/B 2.37 2.95 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA 29.78 n/m 11.54
EV/Sales 2.86 2.46 2.24
Earnings yield (0.28%) (11.04%) (10.09%)
Free cash flow yield (1.23%) (8.47%) (8.47%)

Profitability

Metric AORT PRCT Medical Devices median
Gross margin 64.37% 64.22% 56.01%
Operating margin 4.38% (33.86%) (15.03%)
Net margin (0.67%) (32.54%) (20.40%)
Free cash flow margin (1.94%) (25.17%) (7.24%)
Return on equity (0.73%) (30.24%) (15.32%)
Return on assets (0.33%) (22.12%) (19.72%)
Return on invested capital 1.76% (43.57%) (10.33%)

Growth

Metric AORT PRCT Medical Devices median
Revenue growth (TTM) 16.40% 22.69% 8.80%
EPS growth (last fiscal year) 165.63% 1.71% 29.03%
Revenue growth, 5-year CAGR 11.75% 109.04% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AORT PRCT Medical Devices median
Debt to equity 0.82 0.15 0.07
Current ratio 3.47 6.55 2.50
Net debt to EBITDA 2.72 2.41 0.49

Dividend

Metric AORT PRCT Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric AORT PRCT Medical Devices median
Market cap 1.07b 1.04b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack